UnicomIG, published by UNICOM. This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/hl7-eu/unicom-ig and changes regularly. See the Directory of published versions
: Cefuroxime-MIP-1500mg-EE-MPD - XML Representation
Raw xml | Download
<MedicinalProductDefinition xmlns="http://hl7.org/fhir">
<id value="Cefuroxime-MIP-1500mg-EE-MPD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="Cefuroxime-MIP-1500mg-EE-MPD"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicinalProductDefinition "Cefuroxime-MIP-1500mg-EE-MPD" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-PPLMedicinalProductDefinition.html">PPL Medicinal Product profile</a></p></div><p><b>identifier</b>: id: EE-100009199-27834, id: EE0000002</p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-domain-ema-cs.html">Domain EMA</a>#100000000012)</span></p><p><b>status</b>: Current <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-recordStatus-ema-cs.html">Record Status EMA SPOR</a>#200000005004)</span></p><p><b>combinedPharmaceuticalDoseForm</b>: Powder for solution for injection/infusion <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-pharmaceutical-dose-form-ema-cs.html">Pharmaceutical Dose Form EMA</a>#100000116186)</span></p><p><b>legalStatusOfSupply</b>: Medicinal Product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-legal-status-for-the-supply-ema-cs.html">Legal Status for the Supply EMA</a>#100000072084)</span></p><p><b>classification</b>: Cefuroxime <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-ATC-Human-EMA.html">ATC Human EMA</a>#100000096183)</span>, cefuroxime <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html">WHO ATC</a>#J01DC02)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Cefuroxime MIP 1500 mg, süste-/infusioonilahuse pulber</p><blockquote><p><b>namePart</b></p><p><b>part</b>: Cefuroxime MIP</p><p><b>type</b>: Invented name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>namePart</b></p><p><b>part</b>: 1500 MG</p><p><b>type</b>: Strength part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000004)</span></p></blockquote><h3>CountryLanguages</h3><table class="grid"><tr><td>-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>Republic of Estonia <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-country-ema-cs.html">Country EMA</a>#100000000388)</span></td><td>Estonian <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-language-ema-cs.html">Language EMA</a>#100000072172)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/fhir/mpId"/>
<value value="EE-100009199-27834"/>
</identifier>
<identifier>
<system value="http://ema.europa.eu/fhir/pmsId"/>
<value value="EE0000002"/>
</identifier>
<domain>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000004"/>
<code value="100000000012"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000005003"/>
<code value="200000005004"/>
<display value="Current"/>
</coding>
</status>
<combinedPharmaceuticalDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000116186"/>
<display value="Powder for solution for injection/infusion"/>
</coding>
</combinedPharmaceuticalDoseForm>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072051"/>
<code value="100000072084"/>
<display value="Medicinal Product subject to medical prescription"/>
</coding>
</legalStatusOfSupply>
<classification>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000093533"/>
<code value="100000096183"/>
<display value="Cefuroxime"/>
</coding>
</classification>
<classification>
<coding>
<system value="http://www.whocc.no/atc"/>
<code value="J01DC02"/>
<display value="cefuroxime"/>
</coding>
</classification>
<name>
<productName
value="Cefuroxime MIP 1500 mg, süste-/infusioonilahuse pulber"/>
<namePart>
<part value="Cefuroxime MIP"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000002"/>
<display value="Invented name part"/>
</coding>
</type>
</namePart>
<namePart>
<part value="1500 MG"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000004"/>
<display value="Strength part"/>
</coding>
</type>
</namePart>
<countryLanguage>
<country>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000388"/>
<display value="Republic of Estonia"/>
</coding>
</country>
<language>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072057"/>
<code value="100000072172"/>
<display value="Estonian"/>
</coding>
</language>
</countryLanguage>
</name>
</MedicinalProductDefinition>
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
